Bona Releases 2021 Sustainability Report
Bona ®, a global, sustainably-driven company that supplies products for installing, renovating, maintaining and restoring premium floors, today released the results of its 2021 Sustainability Report. The report highlights Bona’s most significant sustainability milestones for the year focused on its commitment to betterment for home, health, and humanity.
“Our commitment and responsible approach to the environment, people and society has remained steadfast for more than 100 years,” said Kerstin Lindell, Chair of the Board, Bona AB. “This past year presented some challenges, including supply chain and raw materials shortages, yet Bona stayed flexible and focused. Thanks to our fantastic team, our promise to deliver the best products and systems to our customers never wavered and we continue to identify more sustainable solutions. The ability to quickly shift, work together, and develop products and offerings despite changing market conditions has been key to our success.”
Sustainable development on the agenda
In 2021, Bona made some significant investments in its commitment to a sustainable future. The first was the introduction of an electric truck to Bona’s transportation fleet in Limburg, Germany. The electric truck will contribute to lower nitrogen dioxide levels in the city of Limburg and to global decarbonization. In Sweden, Bona invested in a geothermal system that will provide Bona’s Malmö facility with geothermal energy offsetting 20 percent of the yearly energy use at the facility. Another significant milestone last year was the purchase of 26,000-square-meters of land to build a new facility in Monroe, North Carolina, USA. The project, which will be completed in 2022, supports more efficient operations and increased internal capabilities allowing Bona US to operate in a more environmentally friendly way.
Björn Johansson Global Environmental Manager at Bona, said, “We continue to take important steps forward by increasing our use of renewable energy, smarter materials and packaging that uses less virgin plastic, and exhaustively researching new and better ingredients for our products. While we still have work to do, 2021 was a year where we made good progress.”
Highlights of the year
Bona’s core offering encourages care, maintenance, and renovation of hard flooring surfaces such as wood and resilient rather than replacing these materials thereby safeguarding the earth’s finite resources. In 2021 Bona produced finishes, stains, and sealers to cover more than 43 million square meters of wood flooring, saving a forest area equal to approximately 32 million square meters. By not cutting down the forest, the same number of trees encapsulates 28,917 tonnes of carbon dioxide (CO2), calculated as 9-ton CO by hectare and year.
Also in 2021, Bona initiated the use of 90 percent post-consumer recycled (PCR) material in its microfiber pads designed for the Bona Spray Mop and Bona Microfiber Mop. Aligning to the company’s goal to use less virgin plastic, this shift is helping divert over 217 tons of plastic waste from being incinerated or going to landfills.
In the autumn of last year, Bona received the Safer Choice Partner of the Year Award from the US Environmental Protection Agency (EPA) for its work innovating better ingredients in its floor cleaning solutions. Since becoming a Safer Choice partner in 2020, Bona has certified 13 products, six of which were certified in 2021.
Other key facts
Additional notable facts from Bona’s 2021 Sustainability report include:
- Five years ago, Bona moved its adhesive product from buckets to a tube packaging called “sausages.” In 2021 Bona reduced its environmental footprint by using sausages rather than buckets and over the past five years Bona has avoided using more than 258,000 buckets which is a carbon savings of 243,281 kg.
- An innovative ergonomic tool was launched 2021 as a new addition to the Bona FlexiSand Pro System. The Bona ErgoEdge is a machine attachment that allows flooring contractors to achieve smooth, efficient sanding in corners and edges of a floor without kneeling or bending by attaching to an existing, standing machine. This innovation saves time and offers a more ergonomic experience for the contractor all while providing a premium floor sanding experience.
- In 2021 Bona released several new products all of which were formulated with Bona’s commitment to greener chemistry including amplified formulas of its Bona Hardwood Floor and Bona Hard-Floor cleaning solutions. The formulations are water-based, biodegradable, meet the U.S. EPA product standards, and are Safer Choice Certified.
- Since 2016, Bona has collaborated with Hand in Hand, a non-governmental organization (NGO) that fights poverty with grassroots entrepreneurship, to increase the quality of life for three villages in India. With the organizations Village Upliftment Program, Bona’s partnership has helped improve living conditions for women and children through education and the creation of new jobs.
About the framework of Bona’s 2021 Sustainability Report
For the fifth year in a row, Bona reported the company's sustainability work in accordance with Swedish law and standards. The 2021 Sustainability Report aligns to the UN Sustainability goals and summarizes the sustainability information in the four areas of environment, social conditions, personnel and respect for human rights and the fight against corruption. View the full report at bona.com/sustainability
About Bona
Bona is a family-owned, sustainably driven company that supplies products for installing, renovating, maintaining and restoring premium floors. Founded in 1919, Bona was the first in the industry to offer a full system of waterborne hardwood floor finishing and floor care products. Today, Bona offers products for most premium floor surfaces including wood, tile, vinyl, resilient, rubber and laminate. Bona’s turnover is 3.1bn SEK (EUR 307 million) 2021. The head office is in Malmö, Sweden, and the company is represented globally by its 17 subsidiaries, 70 distributors, 4 production units and 600 employees. For more visit www.bona.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220405005107/en/
Contact information
Heather Lindemann | Bona
+1 (800) 872-5515
heather.lindemann@bona.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
